111 related articles for article (PubMed ID: 16398216)
1. Relationship between angiogenesis and grade of histologic differentiation in endometrial adenocarcinoma.
de Góis Speck NM; Focchi J; Alves AC; Ribalta JC; Osório CA
Eur J Gynaecol Oncol; 2005; 26(6):599-601. PubMed ID: 16398216
[TBL] [Abstract][Full Text] [Related]
2. [The relationship between the pathologic features of the uninvolved endometrium and prognosis in postmenopausal endometrial carcinoma].
Wang L; Zhou X; Du X
Zhonghua Fu Chan Ke Za Zhi; 1997 Oct; 32(10):605-8. PubMed ID: 9642377
[TBL] [Abstract][Full Text] [Related]
3. Expression of aquaporin-1 in normal, hyperplasic, and carcinomatous endometria.
Pan H; Sun CC; Zhou CY; Huang HF
Int J Gynaecol Obstet; 2008 Jun; 101(3):239-44. PubMed ID: 18313673
[TBL] [Abstract][Full Text] [Related]
4. Endometrioid endometrial carcinoma with atrophic endometrium and poor prognosis.
Geels YP; Pijnenborg JM; van den Berg-van Erp SH; Bulten J; Visscher DW; Dowdy SC; Massuger LF
Obstet Gynecol; 2012 Nov; 120(5):1124-31. PubMed ID: 23090531
[TBL] [Abstract][Full Text] [Related]
5. Expression of tumor suppressor gene product p14ARF in endometrioid adenocarcinoma of the uterine corpus.
Watanabe J; Nishizaki R; Jobo T; Kamata Y; Hata H; Nishimura Y; Fujisawa T; Okayasu I; Kuramoto H
Int J Gynecol Pathol; 2004 Jul; 23(3):234-40. PubMed ID: 15213599
[TBL] [Abstract][Full Text] [Related]
6. Pathological findings in early-stage endometrial cancer.
Zehavi S; Schneider D; Bukovsky I; Halperin R
Eur J Gynaecol Oncol; 2003; 24(1):18-20. PubMed ID: 12691310
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of prognostic factors in poorly differentiated (G3) endometrioid adenocarcinoma in Japan.
Kuwabara Y; Susumu N; Banno K; Hirao T; Kawaguchi M; Yamagami W; Suzuki N; Aoki D; Nozawa S
Jpn J Clin Oncol; 2005 Jan; 35(1):23-7. PubMed ID: 15681600
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis in normal, hyperplastic, and neoplastic endometrium.
Morgan KG; Wilkinson N; Buckley CH
J Pathol; 1996 Jul; 179(3):317-20. PubMed ID: 8774489
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis in endometrial carcinoma: correlation with survival and clinicopathologic risk factors.
Ozuysal S; Bilgin T; Ozan H; Kara HF; Oztürk H; Ercan I
Gynecol Obstet Invest; 2003; 55(3):173-7. PubMed ID: 12865598
[TBL] [Abstract][Full Text] [Related]
10. L-type amino acid transporter 1 expression increases in well-differentiated but decreases in poorly differentiated endometrial endometrioid adenocarcinoma and shows an inverse correlation with p53 expression.
Watanabe J; Yokoyama Y; Futagami M; Mizunuma H; Yoshioka H; Washiya K; Hana K; Endou H; Okayasu I
Int J Gynecol Cancer; 2014 May; 24(4):659-63. PubMed ID: 24694899
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D1 expression in endometrioid-type endometrial adenocarcinoma is correlated with histological grade and proliferative activity, but not with prognosis.
Nishimura Y; Watanabe J; Jobo T; Kato N; Fujisawa T; Kamata Y; Kuramoto H
Anticancer Res; 2004; 24(4):2185-91. PubMed ID: 15330159
[TBL] [Abstract][Full Text] [Related]
12. Proliferative activity in postmenopausal endometrium: the lurking potential for giving rise to an endometrial adenocarcinoma.
Sivridis E; Giatromanolaki A
J Clin Pathol; 2004 Aug; 57(8):840-4. PubMed ID: 15280405
[TBL] [Abstract][Full Text] [Related]
13. GLUT-1 Expression in Proliferative Endometrium, Endometrial Hyperplasia, Endometrial Adenocarcinoma and the Relationship Between GLUT-1 Expression and Prognostic Parameters in Endometrial Adenocarcinoma.
Canpolat T; Ersöz C; Uğuz A; Vardar MA; Altintaş A
Turk Patoloji Derg; 2016; 32(3):141-7. PubMed ID: 27562387
[TBL] [Abstract][Full Text] [Related]
14. Correlation of mast cell density, tumor angiogenesis, and clinical outcomes in patients with endometrioid endometrial cancer.
Pansrikaew P; Cheewakriangkrai C; Taweevisit M; Khunamornpong S; Siriaunkgul S
Asian Pac J Cancer Prev; 2010; 11(2):309-12. PubMed ID: 20843106
[TBL] [Abstract][Full Text] [Related]
15. Altered extent, pattern and characteristics of microvascular density are indicators of neoplastic progression in the endometrium.
Näyhä V; Viitanen T; Stenbäck F
Int J Cancer; 2005 Jul; 115(6):975-80. PubMed ID: 15723304
[TBL] [Abstract][Full Text] [Related]
16. Cytological evaluation of angiogenesis in endometrial aspirates.
Ono M; Shiina Y
Cytopathology; 2001 Feb; 12(1):37-43. PubMed ID: 11256935
[TBL] [Abstract][Full Text] [Related]
17. The use of an immunocytochemical double-labeling staining can display the distribution of Bcl-2/Ki-67 cells in endometrial adenocarcinomas as well as in normal endometrium.
Mourtzikou A; Kosmas K; Marouga A; Stamouli M; Pouliakis A; Karakitsos P
Clin Lab; 2012; 58(1-2):133-44. PubMed ID: 22372356
[TBL] [Abstract][Full Text] [Related]
18. Villoglandular adenocarcinoma of the endometrium.
Ambros RA; Malfetano JH
Am J Surg Pathol; 2000 Jan; 24(1):155-6. PubMed ID: 10632501
[No Abstract] [Full Text] [Related]
19. Correlation of mast cell density, tumor angiogenesis, and clinical outcomes in patients with endometrioid endometrial cancer.
Pansrikaew P; Cheewakriangkrai C; Taweevisit M; Khunamornpong S; Siriaunkgul S
Asian Pac J Cancer Prev; 2010; 11(3):623-6. PubMed ID: 21039027
[TBL] [Abstract][Full Text] [Related]
20. PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus.
Kimura F; Watanabe J; Hata H; Fujisawa T; Kamata Y; Nishimura Y; Jobo T; Kuramoto H
J Cancer Res Clin Oncol; 2004 Mar; 130(3):161-8. PubMed ID: 14689303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
